<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: clinicaltrials.gov</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'clinicaltrials.gov'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22clinicaltrials.gov%22&t=%22clinicaltrials.gov%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:58:17 +0100</lastBuildDate>
        <item>
            <title>Industry Funded Clinical Trials &amp; Biased Publication</title>
            <link>http://www.medworm.com/index.php?rid=3816758&amp;cid=t_92665_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FmShjsSO3yyM%2F</link>
            <description>A new study finds that clinical trials funded by the pharmaceutical industry are more likely to report a positive outcome, but less likely to be published shortly after completion than trials funded by other sources, such as the federal government, non-profit groups or academia. Unlike previous studies on this topic, the researchers say their study broadens the debate because they made a point of examining 546 trials that were registered on ClinicalTrials.gov and involved five widely used classes of meds for treating depression, high cholesterol, high blood pressure, heartburn and schizophrenia.
All of the trials occurred between 2000 and 2006. The study, which was published in The Annals of Internal Medicine, found 346 trials, or 63 percent, were primarily funded by industry, 74 or 14 per...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3816758</comments>
            <pubDate>Tue, 03 Aug 2010 14:50:41 +0100</pubDate>
            <guid isPermaLink="false">3816758</guid>        </item>
        <item>
            <title>Nationwide Registry to “Match” Study Volunteers With Researchers</title>
            <link>http://www.medworm.com/index.php?rid=2984986&amp;cid=t_92665_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F11%2F11%2Fnationwide-registry-to-match-study-volunteers-with-researchers%2F</link>
            <description>Individuals who want to participate in research studies can connect online with researchers nationwide through the first disease-neutral, volunteer recruitment registry.  ResearchMatch.org is a not-for-profit secure Web site, designed to provide people who are interested in participating in research the opportunity to be matched with studies that may be the right fit for them.

NIH Announces [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2984986</comments>
            <pubDate>Thu, 12 Nov 2009 06:32:15 +0100</pubDate>
            <guid isPermaLink="false">2984986</guid>        </item>
        <item>
            <title>Looking For Published Cancer Trials? Fuggedaboutit</title>
            <link>http://www.medworm.com/index.php?rid=1802936&amp;cid=t_92665_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F394244811%2F</link>
            <description>Less than 20 percent of registered clinical trials of cancer meds are eventually published in medical journals, according to a reviewy published online today by the The Oncologist medical journal. 
A search of the National Institutes of Health&amp;#8217;s ClinicalTrials.gov web site identified 2,028 registered research studies of cancer treatments. Major medical journals, you may recall, require all studies considered for publication be registered at ClinicalTrials.gov or another publicly accessible database. And a subsequent search of the National Library of Medicine&amp;#8217;s PubMed database showed that just 17.6 percent of the trials were eventually published in peer-reviewed medical journals. 
The publication rate was particularly low for &amp;#8220;industry-sponsored&amp;#8221; studies, such as tho...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1802936</comments>
            <pubDate>Tue, 16 Sep 2008 14:26:15 +0100</pubDate>
            <guid isPermaLink="false">1802936</guid>        </item>
        <item>
            <title>Cancer Grabs Largest Share Of Clinical Trials</title>
            <link>http://www.medworm.com/index.php?rid=1720553&amp;cid=t_92665_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F370003556%2F</link>
            <description>Since the International Committee of Medical Journal Editors began requiring clinical trials to be registered in a public trial registry at their outset as a condition of publication, ClinicalTrials.gov has become a useful repository of interesting data, Nature Reviews notes. And so a report examined all &amp;#8220;industry-sponsored&amp;#8221; Phase II through Phase IV studies on November 1, 2007, including trials that were first registered between October 2005 and September 2007. 
And what do we learn? Most registered trials were in oncology, followed by central nervous system disorders, cardiology, infectious diseases, endocrinology, and respiratory diseases. These six therapeutic areas accounted for 68 percent of 3,515l protocols and 74 percent of 94,135 sites. The number of registered trials ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1720553</comments>
            <pubDate>Wed, 20 Aug 2008 14:12:36 +0100</pubDate>
            <guid isPermaLink="false">1720553</guid>        </item>
        <item>
            <title>Clinical trial registration</title>
            <link>http://www.medworm.com/index.php?rid=397037&amp;cid=t_92665_86_f&amp;fid=34466&amp;url=http%3A%2F%2Fclinicalevidence.blogspot.com%2F2007%2F01%2Fclinical-trial-registration.html</link>
            <description>In an editorial by Drazen and Zarin in this week's NEJM, &quot;Salvation by Registration,&quot; there's a brief tale about an author who submitted a paper to the journal, and the reported trial was incorrectly entered into clinicaltrials.gov - the paper was initially refused due to this issue, and it turned out that the trial's sponser was responsible for the incomplete record in the database. One of the co-authors inadvertently worked around this issue by creating a new, complete and accurate record, and the paper is included in this week's issue.The editorial points out the importance of a complete trial protocol submission to a public registry in compliance with the ICMJE initiative; they also point to the ineffectiveness of duplicate efforts on the part of the study sponsor and the study investi...</description>
            <author>Clinical Evidence, Searching Tidbits, and Other Minutiae</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=397037</comments>
            <pubDate>Thu, 11 Jan 2007 22:18:00 +0100</pubDate>
            <guid isPermaLink="false">397037</guid>        </item>
    </channel>
</rss>

